Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY(®)) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 Study

por Jones, Aksana, Cohen-Barak, Orit, Radivojevic, Andrijana, Fiedler-Kelly, Jill
Publicado 2021

A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis

por Naik, Himanshu, Tsai, Max C., Fiedler-Kelly, Jill, Qiu, Ping, Vakilynejad, Majid
Publicado 2013

Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses

por Fiedler‐Kelly, Jill, Passarell, Julie, Ludwig, Elizabeth, Levi, Micha, Cohen‐Barak, Orit
Publicado 2020

Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures

por Sunkaraneni, Soujanya, Ludwig, Elizabeth, Fiedler-Kelly, Jill, Hopkins, Seth, Galluppi, Gerald, Blum, David
Publicado 2018

Population Pharmacokinetic Analysis for Plasma and Epithelial Lining Fluid Ceftolozane/Tazobactam Concentrations in Patients With Ventilated Nosocomial Pneumonia

por Zhang, Zufei, Patel, Yogesh T., Fiedler‐Kelly, Jill, Feng, Hwa‐Ping, Bruno, Christopher J., Gao, Wei
Publicado 2020

Population pharmacokinetic modelling and simulation of fremanezumab in healthy subjects and patients with migraine

por Fiedler‐Kelly, Jill B., Cohen‐Barak, Orit, Morris, Denise N., Ludwig, Elizabeth, Rasamoelisolo, Michele, Shen, Honglue, Levi, Micha
Publicado 2019

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy

por Sunkaraneni, Soujanya, Passarell, Julie A, Ludwig, Elizabeth A, Fiedler-Kelly, Jill, Pitner, Janet K, Grinnell, Todd A, Blum, David
Publicado 2017

Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia and End‐...

por Feng, Hwa‐Ping, Patel, Yogesh T., Zhang, Zufei, Fiedler‐Kelly, Jill, Bruno, Christopher J., Rhee, Elizabeth G., De Anda, Carisa, Gao, Wei
Publicado 2022

Exposure–Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP

por Gao, Wei, Passarell, Julie, Patel, Yogesh T., Zhang, Zufei, Lin, Gina, Fiedler-Kelly, Jill, Bruno, Christopher J., Rhee, Elizabeth G., De Anda, Carisa S., Feng, Hwa-Ping
Publicado 2022

Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections

por Ortiz-Covarrubias, Alejandro, Fang, Edward, Prokocimer, Philippe G., Flanagan, Shawn D., Zhu, Xu, Cabré-Márquez, Jose Francisco, Tanaka, Toshiaki, Passarell, Julie, Fiedler-Kelly, Jill, Nannini, Esteban C.
Publicado 2016

Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia

por Kang, Dongwoo, Ludwig, Elizabeth, Jaworowicz, David, Huang, Hannah, Fiedler-Kelly, Jill, Cortes, Jorge, Ganguly, Siddhartha, Khaled, Samer, Krämer, Alwin, Levis, Mark, Martinelli, Giovanni, Perl, Alexander, Russell, Nigel, Abutarif, Malaz, Choi, Youngsook, Yin, Ophelia
Publicado 2021

Population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid Leukemia

por Kang, Dongwoo, Ludwig, Elizabeth, Jaworowicz, David, Huang, Hannah, Fiedler‐Kelly, Jill, Cortes, Jorge, Ganguly, Siddhartha, Khaled, Samer, Krämer, Alwin, Levis, Mark, Martinelli, Giovanni, Perl, Alexander, Russell, Nigel, Abutarif, Malaz, Choi, Youngsook, Mendell, Jeanne, Yin, Ophelia
Publicado 2020